February 27, 2024 · Form 4 insider transaction
Giladi Moshe bought 51,124 shares of NovoCure Limited at $16.30 per share, a transaction worth $833.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.